COVID-19: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir | India News,The Indian Express

COVID-19: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir | India News,The Indian Express

COVID-19: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir

Cipla and Hetero Labs have already entered into non-exclusive licensing agreements with US pharma giant Gilead Sciences, which is the patent holder of the drug remdesivir.